#USA #New York #PR Newswire #Health Press Releases #Health Updates

Highlights from This Week's Health Press Releases

Staying on top of the latest developments in healthcare can be overwhelming, especially with the sheer volume of news entering the marketplace weekly. This week's collection of notable health press releases from PR Newswire captures essential stories that healthcare professionals and consumers should not overlook. From corporate acquisitions to groundbreaking research studies, each press release offers a concise overview of major advancements and findings in the health sector.

Key Health Developments

1. Sun Pharma Acquires Checkpoint Therapeutics
In a significant move, Sun Pharma announced its plans to acquire Checkpoint Therapeutics. The acquisition is set to advance the availability of UNLOXCYT, an innovative immunotherapy aimed at addressing metastatic cutaneous squamous cell carcinoma (cSCC). This merger is seen as a vital step towards better treatment options for patients suffering from this aggressive cancer.

2. Labcorp Expands Oncology Services by Acquiring BioReference Health's Assets
Labcorp will broaden its reach in the oncology sector by acquiring specific assets from BioReference Health, focusing on clinical testing services. This new acquisition, valued at $85 - $100 million in annual revenue, is expected to enhance lab testing capabilities across the United States.

3. National Sleep Foundation Reveals Sleep Apnea Treatment Gaps
Recent research by the National Sleep Foundation highlights a critical gap in the treatment of sleep apnea, revealing that approximately one-third of diagnosed individuals are not receiving necessary care. Alarmingly, 78% of respondents lacked awareness of available treatment options and only a quarter could identify the health risks associated with untreated sleep apnea. This data underscores the urgent need for increased public education on sleep disorders.

4. Groundbreaking Results from Amgen and Kyowa Kirin's IGNITE Study
The Phase 3 IGNITE study demonstrated promising results for Rocatinlimab, showing significant improvements for patients suffering from moderate to severe atopic dermatitis. The study met all primary and secondary endpoints, reinforcing the treatment's efficacy compared to placebo groups.

5. Healthgrades Unveils Top U.S. Hospitals for Patient Safety
Celebrating excellence in patient care, Healthgrades has named 442 hospitals from 40 states as the best for patient safety. These establishments represent the top 10% in the nation, illustrating advancements in minimizing complications and serious injuries during hospital visits.

6. FDA Approves OMLYCLO® as the First Interchangeable Biosimilar
The FDA has granted approval for Celltrion's OMLYCLO®, the first and only biosimilar referencing XOLAIR®, to achieve an interchangeable designation. This approval is anticipated to increase accessibility and potentially reduce costs for patients with asthma and allergic conditions.

7. Make-A-Wish Receives Generous Grant from U.S. Bank Foundation
A grant of $250,000 from the U.S. Bank Foundation will significantly support the Make-A-Wish Foundation in fulfilling life-changing wishes for children in need. This initiative aims to replace fear with hope, revitalizing the spirits of children facing critical illnesses.

8. MyFitnessPal's Nutrition IQ Survey Highlights Dietary Challenges
As economic pressures grow, MyFitnessPal's latest survey exposes Americans' nutritional challenges, showcasing how rising food prices complicate access to healthy food alternatives amid popular health resolutions typically set at the beginning of the year.

9. Hashimoto's Disease Awareness Day Launched
March 12 marks the inaugural Hashimoto's Disease Awareness Day, aiming to increase recognition and understanding of Hashimoto's thyroiditis—a condition affecting millions but often misdiagnosed or overlooked.

10. American Diabetes Association Honors Achievements in Diabetes Care
The ADA recently announced the winners of their National Scientific and Health Care Achievement Awards, commending healthcare professionals for their contributions towards a diabetes-free world through advancements in research and treatment.

11. Baricitinib Offers Hope for Adolescents with Alopecia Areata
Lilly's recent study has highlighted the effectiveness of baricitinib in achieving substantial hair regrowth in adolescents with severe alopecia areata, with results showcasing its status as the most thoroughly researched JAK inhibitor in this area.

12. HIMSS25 Conference Concludes
Informa Connect lauded a successful HIMSS25 conference, revealing plans for HIMSS26. With over 600 educational sessions and 950 exhibitors, the event fostered essential discussions about the evolution of healthcare technologies.

13. Spouses of Patients Experience Enhanced Quality of Life Post-Surgery
A recent study indicated that 70% of spouses of hip and knee replacement patients experienced an increase in their quality of life following their partner's surgery, showcasing the broader impacts of health improvements on familial well-being.

14. Sesame Place Launches Hidden Disabilities Sunflower Program
Embracing inclusivity, Sesame Place Philadelphia has introduced a Hidden Disabilities Sunflower Program designed to assist guests with non-visible disabilities, ensuring they receive the necessary accommodations for an enjoyable experience.

15. Count Me In Initiates Research on Rare Kidney Cancer
In response to the limited research surrounding translocation renal cell carcinoma (tRCC), Count Me In has initiated a new patient-partnered research project to address the challenges faced by patients with this rare cancer.

These highlights represent just a fraction of the groundbreaking advancements happening in the healthcare landscape. Keeping abreast of such developments is crucial for journalists, healthcare professionals, and interested consumers alike. For more health-related press releases, be sure to visit PR Newswire, where you can sign up for tailored newsfeeds that cater to your specific interests.